Fig. 5. Pcm heterozygous mutant spleens exhibit functional competence for
red pulp hyperplasia and red blood cell clearance. (A) Spleen weights
demonstrate a transient increase in Pcm heterozygotes at 7 weeks of
age. *, P<0.01. Phenylhydrazine treatment of 3-week (B)
and 7-week-old mice (C) demonstrates reduced splenic hyperplasia in
Pcm heterozygotes. **, P<0.0001. (D) Prussian
blue staining of P0 spleen reveals no iron accumulation in wild-type or
Pcm heterozygous mutants. Original magnification, 200x. (E) At
12 weeks of age, Pcm heterozygotes display significant red pulp iron
accumulation. Original magnification, 100x.